Skip to main content

Wine lowers risk of esophageal cancer

Last week the news was that wine is supposedly equal to any other type of alcoholic beverage in encouraging the development of cancer, particularly of the digestive tract, even when consumed in moderate amounts. This week it is the opposite, at least in terms of one especially nasty type of cancer involving the esophagus. Wine drinkers, it turns out, have a lower risk because they tend not to get as much reflux of stomach acid up into the lower esophagus, which causes inflammation. This condition is called Barrett's esophagus and is not only miserable but potentially deadly because it predisposes to cancer.
It reminds me of my days as a general surgery resident, when one of the most common conditions leading to surgery was stomach ulcers. (They are prone to bleeding and numerous other unfortunate consequences.) Standard advice regarding ulcers was to avoid spicy foods and alcohol, in the belief that these encouraged the stomach to produce more acid. It was some years later that we learned that the culprit in most cases was a type of bacteria, which as luck would have it is inactivated by wine polyphenols. So ironically we should have been encouraging these patients to have wine with dinner, contrary to all prevailing logic.
The real point here is that studies of this type, called population studies, require a healthy degree of skepticism in order to derive anything useful. For one thing, they rely on self-reporting of drinking habits, which is notoriously unreliable; for another, there are few populations with consistent drinking patterns anymore. The best information actually comes from studies done years ago when such populations did exist, for example in rural France. These studies consistently find health benefits to regular moderate consumption of wine. The final lesson here is that regular moderate wine drinking is linked to other healthy behaviors, so that it can't be reduced to a chemical formula and put into a pill. So when you see the ads for the newest supplement touting "all the benfits of wine without the alcohol" you know it just ain't so.

Comments

Popular posts from this blog

Versatile resveratrol: the ultimate skin care ingredient?

  Part 1 Recently I was honored to join Professors David Sinclair of Harvard and Joseph Vercauteren of the University of Montpelleir at an anti-aging symposium at the invitation of Mathilde Thomas of Caudalie in Paris. Caudalie has been using wine extracts (and specifically resveratrol) in their products for more than 15 years, after Vercauteren identified it in wine grape vines. Sinclair has become well known for his work identifying the role of sirtuin (SIRT) genes in anti-aging, and resveratrol as a natural sirtuin activator. While much remains to be proven, it is fair to say that science is finally beginning to have an impact on skin care. With an increasing understanding of what causes aging in skin cells and how botanical antioxidants such as resveratrol work at a molecular level, there is no excuse to use anti-aging skin care products that don’t multitask. Before delving into the potential benefits of resveratrol in skin care, it may help to review ho...

Revisiting resveratrol: new findings rekindle anti-aging debate

Just when we thought the bloom was off the rosé for resveratrol, the anti-oxidant polyphenol from red wine with multiple anti-aging properties, along comes new research giving life to the debate. But first a bit of background: As I detailed in my book Age Gets Better with Wine , it is well-documented that wine drinkers live longer and have lower rates of many diseases of aging. Much or the credit for this has been given to resveratrol, though there isn’t nearly enough of it in wine to explain the effects. Nevertheless, I dubbed it the “miracle molecule” and when it was reported to activate a unique life-extension phenomenon via a genetic trigger called SIRT, an industry was born, led by Sirtris Pharmaceuticals, quickly acquired by pharma giant Glaxo. The hope was that resveratrol science could lead to compounds enabling people to live up to 150 years and with a good quality of life. But alas, researchers from other labs could not duplicate the results, and clinical studies disa...